Adamis Pharmaceuticals Corp. (ADMP) Stock Surges Following Promising News of TEMPOL as Potential Covid-19 Treatment
AdamisPharmaceuticals Corp. (ADMP) stock prices were up by a significant 17.84% shortly after market trading commenced on June 7th, 2021, bringing the price per share up to USD$1.1784 early on in the trading day. TEMPOL The company announced on June 7th, 2021 that the National Institute of Health (NIH) had identified the company’s proprietary experimental […]
Oragenics, Inc. (OGEN) Stock Undergoes Volatility Following Changes in Management and Board of Directors
Oragenics, Inc. (OGEN) stock prices were up by 3.32% as of the market closing on April 14th, 2021, bringing the price per share up to USD$0.6199 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock jump by 1.64%, bringing it up to USD$0.62. Net Loss Reports March 3rd, 2021 saw […]
AMC Entertainment Holdings, Inc. (AMC) Stock Trending Up Following Relaxing of Covid-19 Restrictions
AMC Entertainment Holdings, Inc. (AMC) stock prices were up by 1.64% as of the market closing on May 14th, 2021, bringing the price per share up to USD$12.98 at the end of the trading day. Subsequent pre-market fluctuations saw the price increase by another 3.93%, bringing it up to USD$13.49. Re-opening Theatres As of the […]
Cocrystal Pharma, Inc. (COCP) Stock Skyrocketed Following Promising Updates on Covid-19 Drug Development
Cocrystal Pharma, Inc. (COCP) stock prices were up by a monumental 72.58% as of the market closing on may 4th 2021, bringing the price per share up to USD$2.14 at the end of the trading day. Subsequent pre-market fluctuations saw the stock fall by a significant 22.9%, bringing it down to USD$1.65. Covid-19 Treatment Program […]
Vaxart, Inc. (VXRT) Stock Prices Skyrocket Following Announcement of T-cell Webinar
Vaxart, Inc. (VXRT) stock prices were up a staggering 37.46% as of market close on April 27th, 2021, bringing the price per share up to USD$8.33. Novel COVID-19 Tablet With the world hurtling towards COVID-19 solutions for the pandemic, VXRT is setting itself apart from its competitors with a drug, VXA-CoV2-1, that comes in tablet […]
